跳至正文
并购财务顾问 · 亚太区
市场 — 日本

中国买方收购日本医疗健康与消费品牌:信任、团队与渠道

面向中文读者的日本医疗健康与消费品牌并购指南:中国买方评估日本诊所、健康消费、美妆和生活方式品牌时的估值、尽调和交易执行。

Daniel Bae··1分钟阅读

为什么日本品牌和医疗健康资产有吸引力?

日本医疗健康、健康消费、美妆、生活方式和食品品牌在亚洲有较高信任度。中国买方希望通过收购获得品牌、产品、服务标准和区域渠道。

但日本卖方通常重视长期经营和团队稳定。买方需要尊重品牌历史和员工安排。

估值重点

买方应验证品牌资产、商标、产品合规、客户复购、渠道质量、专业人员或创始人留任,以及中国市场增长是否真实可行。

尽调重点

尽调应覆盖财务、客户、供应商、商标、产品配方、牌照、员工、投诉、税务、数据和渠道合同。

交易结构

常见结构包括控股收购、卖方留任、品牌授权、分阶段收购和管理层激励。

Lyndon如何协助

Lyndon可协助中国买方、日本企业主和顾问进行估值、资料室准备、买方沟通和交易执行。

About the Author

Daniel Bae

Daniel Bae

Co-founder & CEO, Lyndon Advisory

Daniel is an investment banker with 15+ years of experience in M&A, having advised on deals worth over US$30 billion. His career spans Citi, Moelis, Nomura, and ANZ across London, Hong Kong, and Sydney. He holds a combined Commerce/Law degree from the University of New South Wales. Daniel founded Lyndon Advisory to solve the pain points in M&A, enabling bankers to focus on what matters most — delivering trusted advice to clients.

About Lyndon Advisory

Lyndon Advisory is an M&A advisory firm built for Asia Pacific. We help business owners sell their companies and investors make strategic acquisitions with senior-led execution, disciplined process management, and AI-supported buyer intelligence.

Learn about selling your business